◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

CARGO THERAPEUTICS, INC.

CIK: 1966494 SIC: 2836
-
Revenue
$-221.78M
Net Income
-
Gross Margin
-
Op. Margin
$-297.82M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 8 of 6 quarterly reports available
Breakdown Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Operating Expenses $52.90M $88.42M $50.13M $47.11M $49.32M $40.81M $34.96M $28.71M
Research & Development $7.51M $30.64M $39.50M $35.93M $37.46M $30.50M $27.07M $22.23M
Operating Income $-52.90M $-88.42M $-50.13M $-47.11M $-49.32M $-40.81M $-34.96M $-28.71M
Interest Expense - - - - - - - $1.60M
Interest Income $3.27M $3.94M $4.67M $5.40M $4.99M $5.00M $3.29M -
Other Income/Expense $-307.00K $-11.00K $31.00K $-199.00K $-17.00K $-10.00K $3.32M $891.00K
Net Income $-49.94M $-84.50M $-45.44M $-41.91M $-44.35M $-35.81M $-32.08M $-35.47M
Basic EPS -1.04 -1.77 -0.95 -0.88 -1.02 -0.87 81.62 -47.37
Diluted EPS -1.04 -1.77 -0.95 -0.88 -1.02 -0.87 81.62 -47.37
Basic Shares Outstanding 48.1M 47.9M 955K 47.7M 43.3M 41.0M 5.3M 749K
Diluted Shares Outstanding 48.1M 47.9M 955K 47.7M 43.3M 41.0M 5.3M 749K
Breakdown Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Cash & Cash Equivalents $107.75M $61.77M $64.38M $71.18M $153.58M $81.53M $405.73M $60.34M
Short-term Investments $144.82M $257.07M $275.32M $333.67M $289.90M $294.39M - -
Other Current Assets $4.99M $4.40M $5.31M $5.17M $4.62M $4.04M $3.75M $3.07M
Total Current Assets $258.61M $324.81M $345.01M $410.02M $448.10M $379.95M $409.48M $63.42M
Property Plant & Equipment - $1.11M $11.29M $11.66M $11.84M $10.61M $10.38M $9.15M
Long-term Investments - $12.44M $28.39M - - - - -
Other Non-current Assets - $93.00K $5.31M $4.65M $4.38M $4.38M $4.39M $7.02M
Total Assets $258.61M $361.96M $414.05M $450.96M $490.01M $422.43M $453.04M $82.41M
Accounts Payable $8.67M $4.23M $2.44M $5.37M $7.01M $7.17M $5.01M $7.43M
Total Current Liabilities $20.91M $51.55M $25.03M $21.64M $26.42M $22.65M $21.16M $41.13M
Other Non-current Liabilities - - - - - - $225.00K $225.00K
Total Liabilities $20.91M $79.50M $53.83M $50.08M $53.91M $49.22M $47.65M $41.66M
Common Stock $46.00K $46.00K $46.00K $46.00K $46.00K $39.00K $41.00K $1.00K
Retained Earnings $-447.08M $-397.15M $-312.65M $-267.21M $-225.31M $-180.96M $-145.15M $-113.07M
Total Stockholders Equity $237.70M $282.46M $360.23M $400.88M $436.10M $373.21M $405.39M $-109.33M
Total Liabilities & Equity $258.61M $361.96M $414.05M $450.96M $490.01M $422.43M $453.04M $82.41M
Breakdown Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Net Income $-134.44M $-84.50M $-45.44M $-122.07M $-80.16M $-35.81M $-32.08M $-35.47M
Stock-based Compensation $12.13M $6.88M $4.83M $13.14M $8.21M $3.90M $1.62M $1.71M
Change in Payables $6.53M $1.60M $-3.15M $1.05M $2.32M $2.67M $-2.54M $3.30M
Operating Cash Flow $-115.08M $-37.69M $-34.89M $-104.86M $-65.23M $-30.15M $-28.98M $-52.18M
Capital Expenditure $481.00K $382.00K $630.00K $3.82M $2.75M $1.29M $2.62M $5.66M
Purchases of Investments $81.69M $81.69M $115.41M $489.46M $360.38M $292.34M - -
Investing Cash Flow $158.40M $35.04M $28.27M $-333.35M $-290.17M $-293.96M $-2.97M $-6.02M
Financing Cash Flow $43.00K $38.00K $-178.00K $103.65M $103.25M $-104.00K $377.91M $116.67M
Net Change in Cash $43.37M $-2.61M $-6.80M $-334.56M $-252.15M $-324.21M $345.95M $58.47M
SEC Filing Format - Data shown as it appears in the Q2 2025 (10-Q) filing Period ended: Jun 30, 2025
Condensed Consolidated Statements of Operations
Description Jun 30, 2025 Jun 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $52.90M - $141.32M -
Research & Development $7.51M - $38.15M -
Operating Income $-52.90M - $-141.32M -
Interest Income $3.27M - $7.21M -
Other Income/Expense $-307.00K - $-318.00K -
Net Income $-49.94M $-35.81M $-134.44M -
Basic EPS -1.04 - -2.80 -
Diluted EPS -1.04 - -2.80 -
Basic Shares Outstanding $48.13M - $47.99M -
Diluted Shares Outstanding $48.13M - $47.99M -
Condensed Consolidated Balance Sheets
Description Jun 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $107.75M $64.38M
Short-term Investments $144.82M $275.32M
Other Current Assets $4.99M $5.31M
Total Current Assets $258.61M $345.01M
Property Plant & Equipment - $11.29M
Long-term Investments - $28.39M
Other Non-current Assets - $5.31M
Total Assets $258.61M $414.05M
Accounts Payable $8.67M $2.44M
Total Current Liabilities $20.91M $25.03M
Total Liabilities $20.91M $53.83M
Common Stock $46.00K $46.00K
Retained Earnings $-447.08M $-312.65M
Total Stockholders Equity $237.70M $360.23M
Total Liabilities & Equity $258.61M $414.05M
Condensed Consolidated Statements of Cash Flows
Description Jun 30, 2025 Jun 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-49.94M $-35.81M $-134.44M -
Stock-based Compensation - - $12.13M -
Change in Payables - - $6.53M -
Operating Cash Flow - - $-115.08M -
Capital Expenditure - - $481.00K -
Purchases of Investments - - $81.69M -
Investing Cash Flow - - $158.40M -
Financing Cash Flow - - $43.00K -
Net Change in Cash - - $43.37M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...